Computational tools for in silico fragment-based drug design

Jérémie Mortier, Christin Rakers, Raphael Frédérick, Gerhard Wolber

Research output: Contribution to journalArticlepeer-review


Fragment-based strategy in drug design involves the initial discovery of low-molecular mass molecules. Owing to their small-size, fragments are molecular tools to probe specific sub-pockets within a protein active site. Once their interaction within the enzyme cavity is clearly understood and experimentally validated, they represent a unique opportunity to design potent and efficient larger compounds. Computer-aided methods can essentially support the identification of suitable fragments. In this review, available tools for computational drug design are discussed in the frame of fragment-based approaches. We analyze and review (i) available commercial fragment libraries with respect to their properties and size, (ii) computational methods for the construction of such a library, (iii) the different strategies and software packages for the selection of the fragments with predicted affinity to a given target, and (iv) tools for the in silico linkage of fragments into an actual high-affinity lead structure candidate.
Original languageEnglish
JournalCurrent Topics in Medicinal Chemistry
Publication statusAccepted/In press - 2012


Dive into the research topics of 'Computational tools for in silico fragment-based drug design'. Together they form a unique fingerprint.

Cite this